Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06293859
Status:
COMPLETED
Last Update Posted:
2024-03-05
First Post:
2024-02-27
Brief Title:
Effect of 12-week Probiotic Consumption Immobilized on Oat Flakes on Blood and Urine Biomarkers and Human Microbiome
Sponsor:
University of the Aegean
Organization:
University of the Aegean
Study Overview
Official Title:
Effect of Daily Lactococcus Cremoris Spp Consumption Immobilized in Oat Flakes on Blood and Urine Biomarkers and Human Microbiome a Randomized Placebo-controlled Clinical Trial
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FOODBIOMES CT2
Brief Summary:
The purpose of this clinical trial was to evaluate the effects Lactococcus cremoris spp im-mobilized on oat flakes on human microbiome and blood and urine biomarkers of associated with human health
Detailed Description:
All eligible and consenting individuals were assigned a unique code for identification purposes They were then randomly assigned to either the probiotic or placebo group The probiotic group received oat flakes containing immobilized Lactococcus cremoris while the placebo group received oat flakes indistinguishable in color smell and taste from the flakes with immobilized probioticsParticipants received written instructions on storing the product which required refrigeration They were instructed to consume 5 g of oats daily with a meal ensuring the meals temperature remained below 35 C and was non-acidic eg with yogurt Biological samples were collected at three time points before intervention at 6th and 12th week
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None